Cargando…

Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity

Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Azushima, Kengo, Tamura, Kouichi, Wakui, Hiromichi, Maeda, Akinobu, Ohsawa, Masato, Uneda, Kazushi, Kobayashi, Ryu, Kanaoka, Tomohiko, Dejima, Toru, Fujikawa, Tetsuya, Yamashita, Akio, Toya, Yoshiyuki, Umemura, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794018/
https://www.ncbi.nlm.nih.gov/pubmed/24130717
http://dx.doi.org/10.1371/journal.pone.0075560
_version_ 1782287165234872320
author Azushima, Kengo
Tamura, Kouichi
Wakui, Hiromichi
Maeda, Akinobu
Ohsawa, Masato
Uneda, Kazushi
Kobayashi, Ryu
Kanaoka, Tomohiko
Dejima, Toru
Fujikawa, Tetsuya
Yamashita, Akio
Toya, Yoshiyuki
Umemura, Satoshi
author_facet Azushima, Kengo
Tamura, Kouichi
Wakui, Hiromichi
Maeda, Akinobu
Ohsawa, Masato
Uneda, Kazushi
Kobayashi, Ryu
Kanaoka, Tomohiko
Dejima, Toru
Fujikawa, Tetsuya
Yamashita, Akio
Toya, Yoshiyuki
Umemura, Satoshi
author_sort Azushima, Kengo
collection PubMed
description Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system.
format Online
Article
Text
id pubmed-3794018
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37940182013-10-15 Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity Azushima, Kengo Tamura, Kouichi Wakui, Hiromichi Maeda, Akinobu Ohsawa, Masato Uneda, Kazushi Kobayashi, Ryu Kanaoka, Tomohiko Dejima, Toru Fujikawa, Tetsuya Yamashita, Akio Toya, Yoshiyuki Umemura, Satoshi PLoS One Research Article Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system. Public Library of Science 2013-10-09 /pmc/articles/PMC3794018/ /pubmed/24130717 http://dx.doi.org/10.1371/journal.pone.0075560 Text en © 2013 Azushima et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Azushima, Kengo
Tamura, Kouichi
Wakui, Hiromichi
Maeda, Akinobu
Ohsawa, Masato
Uneda, Kazushi
Kobayashi, Ryu
Kanaoka, Tomohiko
Dejima, Toru
Fujikawa, Tetsuya
Yamashita, Akio
Toya, Yoshiyuki
Umemura, Satoshi
Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
title Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
title_full Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
title_fullStr Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
title_full_unstemmed Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
title_short Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
title_sort bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794018/
https://www.ncbi.nlm.nih.gov/pubmed/24130717
http://dx.doi.org/10.1371/journal.pone.0075560
work_keys_str_mv AT azushimakengo bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT tamurakouichi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT wakuihiromichi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT maedaakinobu bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT ohsawamasato bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT unedakazushi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT kobayashiryu bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT kanaokatomohiko bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT dejimatoru bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT fujikawatetsuya bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT yamashitaakio bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT toyayoshiyuki bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity
AT umemurasatoshi bofutsushosananorientalherbalmedicineexertsacombinatorialfavorablemetabolicmodulationincludingantihypertensiveeffectonamousemodelofhumanmetabolicdisorderswithvisceralobesity